TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
40 hedge funds and large institutions have $4.04M invested in TFF Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
34% more capital invested
Capital invested by funds: $3.02M → $4.04M (+$1.03M)
21% more funds holding
Funds holding: 33 → 40 (+7)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Carlson Capital
Dallas,
Texas
|
+$1.35M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$412K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$96.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.7K |
| 5 |
Renaissance Technologies
New York
|
+$20.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13.8K |
| 2 |
Millennium Management
New York
|
-$5.14K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.55K |
| 4 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
-$871 |
| 5 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$384 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFG
26
Nations Financial Group
Cedar Rapids,
Iowa
| $4.38K | +$4.68K | +500 | New |
|
|
MWA
27
Meridian Wealth Advisors
Austin,
Texas
| $4.05K | – | – | – |
|
28
Commonwealth Equity Services
Waltham,
Massachusetts
| $4K | – | – | – |
|
|
QPW
29
Quantum Private Wealth
Tampa,
Florida
| $3.88K | – | – | – |
|
|
TDC
30
Thompson Davis & Co
Richmond,
Virginia
| $3.5K | – | – | – |
|
|
VWM
31
Venturi Wealth Management
Austin,
Texas
| $2.9K | +$3.1K | +331 | New |
|
|
NFSG
32
Newbridge Financial Services Group
Boca Raton,
Florida
| $2.19K | +$468 | +50 | +25% |
|
33
Wells Fargo
San Francisco,
California
| $962 | – | – | – |
|
34
Bank of America
Charlotte,
North Carolina
| $878 | -$328 | -35 | -26% |
|
35
Morgan Stanley
New York
| $636 | – | – | – |
|
|
HPC
36
HM Payson & Co
Portland,
Maine
| $525 | – | – | – |
|
37
Group One Trading
Chicago,
Illinois
| $483 | -$150 | -16 | -23% |
|
38
Osaic Holdings
Scottsdale,
Arizona
| $350 | – | – | – |
|
39
JP Morgan Chase
New York
| $21 | +$19 | +2 | New |
|
TFFP Hedge Fund Activity: Q3 2023 in Review
40 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q3 2023, worth a combined $4.04M — up 34% from $3.02M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TFFP positions and 1 closed out — a net gain of 7 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Carlson Capital, adding an estimated $1.35M. The largest seller was UBS Group, cutting an estimated $13.8K.
- 40 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q3 2023, up from 33 in Q2 2023.
- Funds reported $4.04M of TFF Pharmaceuticals, Inc. Common Stock stock for Q3 2023, up 34% quarter-over-quarter.
- 8 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q3 2023 and 1 closed out, a net change of +7 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q3 2023 was Carlson Capital, an estimated $1.35M added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q3 2023 was UBS Group, an estimated $13.8K sold.
Based on aggregated 13F filings for Q3 2023.